LJAC
TDOC icon

L.J. Altfest & Co’s Teladoc Health TDOC Stock Holding History

L.J. Altfest & Co’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,654
Closed -$314K – 206
2019
Q1 		$314K Sell
5,654
-158
-3% -$9.65K 0.08% 139
2018
Q4 		$288K Buy
+5,812
New +$356K 0.08% 120

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

L.J. Altfest & Co's TDOC Position: Q2 2019 in Review

L.J. Altfest & Co sold out of Teladoc Health (TDOC) in Q2 2019, closing a stake of 5,654 shares — an estimated $314K sold.

L.J. Altfest & Co first reported a position in TDOC in Q4 2018 and held it in 2 quarters. The position peaked at $314K in Q1 2019. 371 funds tracked by Wall St. Rank hold TDOC as of Q2 2019.

  • L.J. Altfest & Co reported no remaining Teladoc Health position as of Q2 2019 after selling out during the quarter.
  • L.J. Altfest & Co sold 5,654 Teladoc Health shares in Q2 2019, an estimated $314K.
  • L.J. Altfest & Co first reported a position in Teladoc Health in Q4 2018 and held it in 2 quarters.
  • L.J. Altfest & Co's Teladoc Health position peaked at $314K in Q1 2019.
  • 371 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2019.

Based on L.J. Altfest & Co's 13F filing for Q2 2019, filed 15 Jul 2019.